COMPARISON OF TEMPORAL TRENDS IN THE GLOBAL BURDEN OF TRACHEA, BRONCHIAL, AND LUNG CANCER

Yıl 2022, Cilt: 8 Sayı: 2, 254 - 272, 31.12.2022

İskender Çetintürk , Vahit Yiğit

https://doi.org/10.46849/guiibd.1187956

Öz

Trachea, bronchial, and lung (TBL) cancers are significant public health problems among the leading causes of death in Turkey and the world. In this study, it was aimed to determine and evaluate the temporal trends of incidence, mortality, and DALY rates of TBA cancers between 1990 and 2019. Mortality-Incidence Ratio (MIR) and Joinpoint Regression Analysis (JRA) methods were used in this study. Incidence, mortality, and disability-adjusted life-years were used as variables in the study. The temporal trends of TBL cancers were compared between the global, Turkey, and Socio-Demographic Index (SDI) groups. In this study, it was determined that the age-standardized global burden of TBL cancers tended to decrease between 1990 and 2019. While the burden of TBL cancers tended to decline in high SDI countries during this period, it tended to increase in low SDI countries. In Turkey, while the TBL cancers burden decreased until 2005, it increased after 2006. While the global cancer burden of TBL tended to decline in men, it tended to increase in women during this period. According to the data obtained from the research findings, the burden of TBL cancers tends to decrease globally. However, it tends to increase in low and low-middle SDI group countries. To reduce the TBL global cancer burden, it is recommended that health policies should be developed in both Turkey and international health systems for fair access to cancer treatment.

Anahtar Kelimeler

Trachea Bronchial and Lung Cancer, Mortality-Incidence Ratio, Joinpoint Regression Analysis

Destekleyen Kurum

TUBITAK

Proje Numarası

121K948

Trake, Bronş Ve Akciğer Kanserinin Küresel Yükünün Zamansal Trendlerinin Karşılaştırılması

Öz

Trakea, bronş ve akciğer (TBA) kanserleri hem Türkiye'de hem de dünyada önde gelen ölüm nedenleri arasında yer alan önemli bir halk sağlığı sorunudur. Bu çalışmada, 1990-2019 yılları arasında Trake, bronş ve akciğer (TBA) kanserlerinin insidans, mortalite ve DALY oranlarının zamansal eğilimlerinin belirlenmesi ve değerlendirilmesi amaçlanmıştır. Çalışmada Mortality-Insidans Ratio (MIR) ve Joinpoint Regresyon Analiz (JRA) yöntemi kullanılmıştır. Değişken olarak insidans, mortalite ve engelliliğe göre ayarlanmış yaşam yılları tercih edilmiştir. TBA kanserlerinin zamansal eğilimleri küresel, Türkiye ve Sosyo-Demografik İndeks (SDI) grupları arasında karşılaştırmıştır. Araştırma bulgularında TBL kanserlerinin yaşa göre standardize edilmiş küresel yükü azalma eğiliminde olduğu tespit edilmiştir. TBL kanseri yükü, bu döne içinde yüksek SDI ülkelerde düşme eğiliminde iken, düşük SDI ülkelerde artma eğilimdedir. Türkiye'de ise TBL kanser yükü 2005 yılına kadar azalma eğilimi görülür iken, 2006 yılından sonra artma eğiliminde olduğu tespit edilmiştir. TBL küresel kanser yükü bu dönem içinde erkeklerde azalma eğiliminde iken kadınlarda artma eğilimdedir. Sonuç olarak, TBL kanser yükü küresel olarak düşme eğilimde iken, düşük ve düşük-orta SDI grup ülkelerinde artma eğiliminde olduğu belirlenmiştir. TBL küresel kanser yükünü düşürmek için kanser tedavisine adil erişim için hem Türkiye hem de uluslararası sağlık sistemlerinde sağlık politikaları geliştirilmesi önerilmektedir.

Anahtar Kelimeler

Trakea Bronş ve Akciğer Kanseri, Mortalite İnsidans Oranı, Joinpoint Regresyon Analizi

Proje Numarası

121K948

Kaynakça

• Abbafati, C., Abbas, K. M., Abbasi-Kangevari., … Wiangkham, T. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9
• Ahmad, O. B., Boschi-pinto, C., & Lopez, A. D. (2001). Age standardization of rates: a new WHO standard. GPE Discussion Paper Series, 31, 1–14. http://www.who.int/healthinfo/paper31.pdf
• Almasi, Z., Salehiniya, H., Amoori, N., & Enayatrad, M. (2016). Epidemiology characteristics and trends of lung cancer incidence in Iran. Asian Pacific Journal of Cancer Prevention, 17(2), 557–562. https://doi.org/10.7314/APJCP.2016.17.2.557
• Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492
• Cayuela, A., Rodríguez-Domínguez, S., López-Campos, J. L., & Vigil, E. (2008). Lung cancer mortality trends by geographical area in Spanish women, 1980-2005. International Journal of Tuberculosis and Lung Disease, 12(4), 453–457. Chen, A., Jacobsen, K. H., Deshmukh, A. A., & Cantor, S. B. (2015). The evolution of the disability-adjusted life year (DALY). Socio-Economic Planning Sciences, 49(June 2018), 10–15. https://doi.org/10.1016/j.seps.2014.12.002
• Choi, E., Lee, S., Nhung, B. C., Suh, M., Park, B., Jun, J. K., & Choi, K. S. (2017). Cancer mortality-to-incidence ratio as an indicator of cancer management outcomes in Organization for Economic Cooperation and Development countries. Epidemiology and Health, 39, e2017006. https://doi.org/10.4178/epih.e2017006
• Deng, Y., Peng, L., Li, N., Zhai, Z., Xiang, D., Ye, X., Hu, J., Zheng, Y., Yao, J., Wang, S., Wei, B., Xu, P., Zhang, D., Chen, T., & Dai, Z. (2021). Tracheal, bronchus, and lung cancer burden and related risk factors in the United States and China. American Journal of Translational Research, 13(4), 1928–1951.
• T. A. K., Derneği (2016). Akciğer Kanseri Yol Haritası. Toraks Dergisi, 1, 5-6.
• Doğan, N., Kaçan, T., & Doğan, İ. (2020). Analysis of trends in cancer-related mortality in Turkey. Turkish Oncology Journal, 35(1), 52–57. https://doi.org/10.5505/tjo.2019.2074
• Ellis, L., Woods, L. M., Estève, J., Eloranta, S., Coleman, M. P., & Rachet, B. (2014). Cancer incidence, survival and mortality: Explaining the concepts. International Journal of Cancer, 135(8), 1774–1782. https://doi.org/10.1002/ijc.28990
• Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019). Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. International Journal of Cancer, 144(8), 1941–1953. https://doi.org/10.1002/ijc.31937
• Fernandes, G. A., Menezes, F. dos S., Silva, L. F., Antunes, J. L. F., & Toporcov, T. N. (2020). Inequalities in lung cancer mortality trends in Brazil, 2000–2015. Scientific Reports, 10(1), 1–8. https://doi.org/10.1038/s41598-020-76165-4
• Fitzmaurice, C., Akinyemiju, T. F., Al Lami, ., … Naghavi, M. (2018). Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016 a systematic analysis for the global burden of disease study global burden o. JAMA Oncology, 4(11), 1553–1568. https://doi.org/10.1001/jamaoncol.2018.2706
• Glaziou, P., Sismanidis, C., Zignol, M., & Floyd, K. (2016). Methods used by WHO to estimate the global burden of TB disease. Global TB Programme, WHO, Geneva.WHO. (2020). Global report on health data systems and capacity, 2020. World Health Organization.
• Hébert, J. R., Daguise, V. G., Hurley, D. M., & Bolick-Aldrich, S. W. (2009). Mapping Cancer Mortality-to-Incidence Ratios to Illustrate Racial and Sex Disparities in a High-risk Population. National Institutes of Health, 23(1), 1031–1043. https://doi.org/10.1002/cncr.24270.Mapping
• Institute for Health Metrics and Evaluation (IHME). GBD Compare. Seattle, WA: IHME, University of Washington, Available from http://vizhub.healthdata.org/gbd-compare. (Accessed 10.10.2021)
• Jani, C., Marshall, D. C., Singh, H., Goodall, R., Shalhoub, J., ., & Thomson, C. C. (2021). Lung cancer mortality in Europe and the USA between 2000 and 2017: an observational analysis. ERJ Open Research, 7(4). https://doi.org/10.1183/23120541.00311-2021
• Kim, H., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000). Permutation tests for joinpoint regression with applications to cancer rates. Statistics in Medicine, 19(3), 335–351. https://doi.org/10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.3.co;2-q
• Murray, C. J. L., & Acharya, A. K. (1997). Understanding DALYs. Journal of Health Economics, 16(6), 703–730. https://doi.org/10.1016/S0167-6296(97)00004-0
• Murray, C. J., & Lopez, A. D. (1996). Global burden of disease and injur y series the global burden of disease. OMS, Geneva, Switzerland, 1-46.
• National Cancer Institute Division of Cancer Control & Population Sciences (İnternet). (Erişim Tarihi: 10.10.2020).
• National Cancer Institute Division of Cancer Control & Population Sciences (İnternet). (Erişim Tarihi: 10.10.2020).
• Ni, X., Zhang, B., Xu, N., Zeng, X., & Wang, Q. (2020). Trends and Regional Distribution Pattern of Female Lung Cancer — China, 1992–2016. China CDC Weekly, 2(32), 614–618. https://doi.org/10.46234/ccdcw2020.166
• Robson, B., Purdie, G., Cram, F., & Simmonds, S. (2007). Age standardisation - An indigenous standard? Emerging Themes in Epidemiology, 4, 1–11. https://doi.org/10.1186/1742-7622-4-3
• Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020 : GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA CANCER, 71(3), 209–249. https://doi.org/10.3322/caac.21660
• Türk, M., Yildirim, F., Yurdakul, A. S., & Öztürk, C. (2016). Hospitalization costs of lung cancer diagnosis in Turkey: Is there a difference between histological types and stages? Tuberkuloz ve Toraks, 64(4), 263–268. https://doi.org/10.5578/tt.10132
• Vanthomme, K., Rosskamp, M., De Schutter, H., & Vandenheede, H. (2021). Lung cancer incidence differences in migrant men in Belgium, 2004–2013: histology-specific analyses. BMC Cancer, 21(1), 1–15. https://doi.org/10.1186/s12885-021-08038-6
• Wang, Z., Hu, L., Li, J., Wei, L., Zhang, J., & Zhou, J. (2020). Magnitude, temporal trends and inequality in global burden of tracheal, bronchus and lung cancer: Findings from the Global Burden of Disease Study 2017. BMJ Global Health, 5(10), 1–10. https://doi.org/10.1136/bmjgh-2020-002788
• White, M. C., Holman, D. M., Boehm, J. E., Peipins, L. A., Grossman, M., & Jane Henley, S. (2014). Age and cancer risk: A potentially modifiable relationship. American Journal of Preventive Medicine, 46(3 SUPPL. 1), S7–S15. https://doi.org/10.1016/j.amepre.2013.10.029
• WHO. (2016). International statistical classification of diseases and related health problems ICD-10: instruction manual. World Health Organızatıon -Nternational Statistical Classification of Diseases and Related Health Problems ICD-10: Instruction Manual, 2, 252. https://icd.who.int/browse10/Content/statichtml/ICD10Volume2_en_2016.pdf
• WHO. (2020). Global report on health data systems and capacity, 2020. World Health Organization. Wong, M. C. S., Lao, X. Q., Ho, K. F., Goggins, W. B., & Tse, S. L. A. (2017). Incidence and mortality of lung cancer: Global trends and association with socioeconomic status. Scientific Reports, 7(1), 1–9. https://doi.org/10.1038/s41598-017-14513-7
• Zhong, Y. J., Wen, Y. F., Wong, H. M., Yin, G., Lin, R., & Yang, S. Y. (2019). Trends and patterns of disparities in burden of lung cancer in the United States, 1974-2015. Frontiers in Oncology, 9(MAY). https://doi.org/10.3389/fonc.2019.00404
• Zhou, B., Zang, R., Zhang, M., Song, P., Liu, L., Bie, F., Peng, Y., Bai, G., & Gao, S. (2022). Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: A population-based study. EBioMedicine, 78, 103951. https://doi.org/10.1016/j.ebiom.2022.103951